Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$16.40 -2.3%	$15.71	$8.89 ▼ $24.50	$729.86M	N/A	527,705 shs	514,719 shs
EMBC Embecta	$9.96 -2.0%	$10.27	$9.20 ▼ $21.48	$593.78M	1.08	522,700 shs	673,486 shs
PDEX Pro-Dex	$47.35 -5.4%	$44.75	$17.81 ▼ $70.26	$163.21M	0.19	50,117 shs	43,246 shs
SMLR Semler Scientific	$34.46 -3.9%	$38.02	$21.77 ▼ $81.56	$494.31M	1.34	711,868 shs	858,455 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	-2.32%	+10.51%	+15.98%	+38.63%	+1,639,999,900.00%
EMBC Embecta	-1.97%	-15.09%	-2.83%	-21.76%	-36.44%
PDEX Pro-Dex	-5.39%	-4.21%	+5.11%	+3.25%	+134.17%
SMLR Semler Scientific	-3.88%	-9.51%	-12.85%	-4.70%	+3.95%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BBNX Beta Bionics	2.3526 of 5 stars	4.4	0.0	0.0	1.9	0.8	0.0
EMBC Embecta	4.6458 of 5 stars	3.2	3.0	3.3	2.7	3.3	3.8
PDEX Pro-Dex	2.1828 of 5 stars	2.5	1.0	0.0	3.2	1.7	1.9
SMLR Semler Scientific	2.5482 of 5 stars	3.6	3.0	0.0	2.9	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.75	Moderate Buy	$22.56	37.53% Upside
EMBC Embecta	2.33	Hold	$19.00	90.76% Upside
PDEX Pro-Dex	3.00	Buy	$56.00	18.27% Upside
SMLR Semler Scientific	3.25	Buy	$82.00	137.96% Upside

Current Analyst Ratings Breakdown

Latest PDEX, BBNX, EMBC, and SMLR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2025	BBNX Beta Bionics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$18.00 ➝ $21.00
7/30/2025	BBNX Beta Bionics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Neutral ➝ Neutral	$15.00 ➝ $17.00
7/28/2025	SMLR Semler Scientific	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$61.00
7/28/2025	SMLR Semler Scientific	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$61.00
7/16/2025	EMBC Embecta	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$13.00 ➝ $12.00
7/9/2025	SMLR Semler Scientific	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$95.00
7/8/2025	SMLR Semler Scientific	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$101.00
6/16/2025	BBNX Beta Bionics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$26.00
6/12/2025	BBNX Beta Bionics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$30.00
5/30/2025	BBNX Beta Bionics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$16.00
5/30/2025	BBNX Beta Bionics	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$20.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$65.12M	10.95	N/A	N/A	$6.94 per share	2.36
EMBC Embecta	$1.08B	0.54	$3.27 per share	3.05	($12.80) per share	-0.78
PDEX Pro-Dex	$53.84M	2.87	$0.91 per share	52.27	$9.03 per share	5.24
SMLR Semler Scientific	$56.29M	8.44	$4.30 per share	8.01	$24.90 per share	1.38

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	-$54.76M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
EMBC Embecta	$78.30M	$0.90	11.07	3.24	0.65	4.89%	-19.67%	12.27%	8/8/2025 (Estimated)
PDEX Pro-Dex	$2.13M	$2.80	16.91	22.99	N/A	14.61%	29.08%	16.19%	9/4/2025 (Estimated)
SMLR Semler Scientific	$40.90M	-$2.61	N/A	∞	N/A	-60.69%	19.75%	15.47%	8/4/2025 (Estimated)

Latest PDEX, BBNX, EMBC, and SMLR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/8/2025	Q3 2025	EMBC Embecta	$0.7720	N/A	N/A	N/A	$278.15 million	N/A
8/4/2025	Q2 2025	SMLR Semler Scientific	-$0.27	N/A	N/A	N/A	$8.10 million	N/A
7/29/2025	Q2 2025	BBNX Beta Bionics	-$0.51	-$0.39	+$0.12	-$0.39	$19.73 million	$23.24 million
5/13/2025	Q1 2025	SMLR Semler Scientific	N/A	-$0.76	N/A	-$6.74	N/A	$8.84 million
5/9/2025	Q2 2025	EMBC Embecta	$0.66	$0.70	+$0.04	$0.40	$261.77 million	$259.00 million
5/6/2025	Q1 2025	BBNX Beta Bionics	-$0.51	-$0.52	-$0.01	-$0.93	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
EMBC Embecta	$0.60	6.02%	N/A	66.67%	N/A
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A
SMLR Semler Scientific	N/A	N/A	N/A	N/A	N/A

Latest PDEX, BBNX, EMBC, and SMLR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/5/2025	EMBC Embecta	quarterly	$0.15	4.51%	5/28/2025	5/28/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	14.68	14.93
EMBC Embecta	N/A	2.48	1.83
PDEX Pro-Dex	0.28	2.73	1.45
SMLR Semler Scientific	0.59	0.52	0.51

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
EMBC Embecta	93.83%
PDEX Pro-Dex	15.28%
SMLR Semler Scientific	49.37%

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	N/A
EMBC Embecta	0.42%
PDEX Pro-Dex	47.50%
SMLR Semler Scientific	16.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	43.47 million	N/A	N/A
EMBC Embecta	2,100	58.44 million	58.20 million	Optionable
PDEX Pro-Dex	140	3.26 million	1.71 million	Not Optionable
SMLR Semler Scientific	120	13.79 million	11.53 million	Not Optionable

PDEX, BBNX, EMBC, and SMLR Headlines

Recent News About These Companies

Semler Scientific's Earnings Outlook

August 2 at 11:14 AM | benzinga.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

August 1 at 8:25 PM | globenewswire.com

Pacer Advisors Inc. Takes Position in Semler Scientific Inc. (NASDAQ:SMLR)

July 31 at 6:14 AM | marketbeat.com

Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

July 30 at 5:26 PM | prnewswire.com

SEMLER INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Semler Scientific Inc. on Behalf of Semler Stockholders and Encourages Investors to Contact the Firm

July 29, 2025 | globenewswire.com

Semler Scientific (NASDAQ:SMLR) Upgraded to Strong-Buy at Cantor Fitzgerald

July 29, 2025 | marketbeat.com

Cantor Fitzgerald Initiates Coverage of Semler Scientific (SMLR) with Overweight Recommendation

July 29, 2025 | msn.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 28, 2025 | globenewswire.com

Semler Scientific (SMLR) Expected to Announce Earnings on Monday

July 28, 2025 | marketbeat.com

Semler Scientific (NASDAQ:SMLR) Trading Down 6.3% - Time to Sell?

July 26, 2025 | marketbeat.com

Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

July 25, 2025 | prnewswire.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 24, 2025 | globenewswire.com

Semler Scientific Purchases 175 BTC and Launches Public Bitcoin Dashboard

July 24, 2025 | bitcoinmagazine.com

Semler Scientific Acquires Bitcoin Worth Over $20 Million, Total Holdings Cross 5,000 BTC

July 24, 2025 | msn.com

Semler Scientific® Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results

July 21, 2025 | prnewswire.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 20, 2025 | globenewswire.com

Principal Financial Group Inc. Sells 55,102 Shares of Semler Scientific Inc. (NASDAQ:SMLR)

July 19, 2025 | marketbeat.com

Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

July 18, 2025 | prnewswire.com

Semler Scientific Advances to 14th-Largest Public Bitcoin Holder Following $25 Million Investment

July 18, 2025 | coinspeaker.com

Semler Scientific Becomes 14th-Largest Public Bitcoin Holder After $25M BTC Buy

July 18, 2025 | finance.yahoo.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 17, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDEX, BBNX, EMBC, and SMLR Company Descriptions

Beta Bionics NASDAQ:BBNX

$16.40 -0.39 (-2.32%)

As of 08/1/2025 04:00 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Embecta NASDAQ:EMBC

$9.96 -0.20 (-1.97%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$10.06 +0.10 (+1.00%)

As of 08/1/2025 05:09 PM Eastern

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Pro-Dex NASDAQ:PDEX

$47.35 -2.70 (-5.39%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$47.25 -0.10 (-0.21%)

As of 08/1/2025 04:10 PM Eastern

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Semler Scientific NASDAQ:SMLR

$34.46 -1.39 (-3.88%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$34.67 +0.21 (+0.62%)

As of 08/1/2025 07:57 PM Eastern

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time